Population
1,177 patients with systolic heart failure undergoing implantable cardioverter-defibrillator implantation…
Design
Cohort
Follow-up
average 59 months
Authors
Loading...
Event rates in this primary-prevention ICD cohort do not alter practice; leaves open identification of novel arrhythmic risk factors in systolic HF.
The PROSE-ICD study establishes a large, real-world prospective cohort of patients with systolic heart failure receiving primary-prevention ICDs to identify novel risk factors and mechanisms for arrhythmic sudden death.
Cheng et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: